<DOC>
	<DOCNO>NCT01091376</DOCNO>
	<brief_summary>Concomitant chemoradiotherapy standard treatment locally advance , non-resectable , non-small cell lung cancer ( NSCLC ) . However , optimal chemotherapy regimen still controversial.The objective study evaluate efficacy toxicity concomitant treatment use Erlotinib radiotherapy follow Erlotinib consolidation treatment .</brief_summary>
	<brief_title>Erlotinib Combined With Radiotherapy Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer ( LA-NSCLC )</brief_title>
	<detailed_description>Patients non-resectable Non-small Cell Lung Cancer receive thoracic radiation therapy 60-70 Gy 30-35 fraction concurrent Erlotinib 150mg/day . Followed Erlotinib 150 mg/day consolidation treatment .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Histologically proven nonsmall cell lung cancer ( squamous cell carcinoma , adenocarcinoma , large cell carcinoma etc ) Tumor EGFR mutation Presence measurable disease RECIST stage IIIA IIIB , nonresectable ECOG performance status 02 No prior chemotherapy , radiation therapy chest , immunotherapy , biologic therapy Patients must sign informed consent indicate aware investigational nature study keep policy hospital . Carcinoid tumor , small cell carcinoma lung Patients distant metastasis History another malignancy except cure basal cell carcinoma skin cure carcinoma insitu uterine cervix Any morbidity situation contraindication radiotherapy ( e.g . active infection , myocardial infarction precede 6 month , symptomatic heart disease include unstable angina , congestive heart failure uncontrolled arrhythmia , immunosuppressive treatment ) Pregnant lactate woman , woman take test pregnancy ( within 7 day first administration ) pregnant woman Women men childbearing potential willing employ adequate contraception Tumor EGFR wild</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Non-small cell lung cancer</keyword>
	<keyword>EGFR-TKI</keyword>
	<keyword>Erlotinib</keyword>
	<keyword>Radiotherapy</keyword>
</DOC>